Who
Helen C. Adams
Director
Company insider
Files Form 4 as: Director, Immix Biopharma; Director, Prometheus Biosciences; Director, Genasys.
In numbers
- Trades disclosed
- 21
- Buys
- 2
- Sells
- 0
- Bought
- $48K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 4 May 2010
- Last trade
- 22 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 20 Jun 2025filed 23 Jun 2025 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 11 Jun 2024filed 21 Jun 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 20 May 2024filed 20 May 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —74,241 | filing |
| 15 May 2024filed 20 May 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —87,740 at $0.00 | filing |
| 12 Sep 2023filed 14 Sep 2023 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $38K13,000 at $2.96 | filing |
| 11 Aug 2023filed 14 Aug 2023 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jun 2023filed 16 Jun 2023 | Prometheus Biosciencesoption or derivative | SEC FORM 4 Code D | —30,000 | filing |
| 16 Jun 2023filed 16 Jun 2023 | Prometheus Biosciencesoption or derivative | SEC FORM 4 Code D | —1,083 | filing |
| 16 Jun 2023filed 16 Jun 2023 | Prometheus Biosciencesoption or derivative | SEC FORM 4 Code D | —21,526 | filing |
| 16 Jun 2023filed 16 Jun 2023 | Prometheus Biosciences | SEC FORM 4 Code D | —2,674 | filing |
| 19 May 2023filed 19 May 2023 | Prometheus Biosciences | SEC FORM 4 Code A | —2,174 at $0.00 | filing |
| 14 Jul 2022filed 18 Jul 2022 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 19 May 2022filed 20 May 2022 | Prometheus Biosciencesoption or derivative | SEC FORM 4 Code A | —21,526 at $0.00 | filing |
| 14 Nov 2021filed 16 Nov 2021 | Prometheus Biosciencesoption or derivative | SEC FORM 4 Code A | —1,083 at $0.00 | filing |
| 16 Mar 2021filed 16 Mar 2021 | Prometheus Biosciences | SEC FORM 4 Bought | $9,500500 at $19.00 | filing |
| 10 May 2012filed 10 May 2012 | GNSS Genasysoption or derivative · Electrical Equipment & Grid | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.